The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

SIEGALL CLAY B

Reporting owner CIK 0001167496 · President and CEO · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.SIEGALL CLAY BSIEGALL CLAY BSIEGALL CLAY B · December 30, 2025 · Purchase · Common StockSIEGALL CLAY B · December 19, 2025 · Purchase · Common StockSIEGALL CLAY B · December 18, 2025 · Purchase · Common StockDec 18, 2025Dec 30, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 30, 2025Immunome Inc.Common StockSIEGALL CLAY BPurchase
Dec 19, 2025Immunome Inc.Common StockSIEGALL CLAY BPurchase
Dec 18, 2025Immunome Inc.Common StockSIEGALL CLAY BPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Immunome Inc.IMNM · company listings
SIEGALL CLAY BPresident and CEO · Director
PurchaseCommon StockNon-derivative security · Code P4,72921.15Value: 100,018.35Currency not specifiedView ↗
Trade: Immunome Inc.IMNM · company listings
SIEGALL CLAY BPresident and CEO · Director
PurchaseCommon StockNon-derivative security · Code P7,27820.48 *Value: 149,053.44Currency not specifiedView ↗
Trade: Immunome Inc.IMNM · company listings
SIEGALL CLAY BPresident and CEO · Director
PurchaseCommon StockNon-derivative security · Code P46,51121.5Value: 999,986.5Currency not specifiedView ↗